1 completed, 1 recruiting, 1 unknown. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow cART: new trials by email Literature Review of cART trials Research Report on cART
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study cART + Rilpivirine, cART - Immunological Non-Responders in People With HIV | Phase 2 | Recruiting | Beijing 302 Hospital | 21 | 2026-06-15 | 2026-09-24 |
| Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial. Valganciclovir, Antiretroviral Combinations - Kaposi Sarcoma, Human Immunodeficiency Virus | Phase 2 | Completed | National Institute of Cancerología | 40 | 2015-10-01 | 2022-01-27 |
| Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders Triptolide, cART, placebo - HIV | Phase 1 / Phase 2 | Unknown | LI Taisheng | 150 | 2013-01-01 | 2013-03-25 |
Acquired Immunodeficiency Syndrome (1) · Immune Reconstitution Inflammatory Syndrome (1) · Inflammation (1) · Sarcoma, Kaposi (1)
Beijing 302 Hospital (1) · LI Taisheng (1) · National Institute of Cancerología (1)
China (2) · Mexico (1)